TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

13.20$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement AMRN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
37.8% 34.1% 26.4% 24.8% 23.8% 22.3% 21.4% 20.8% 34.3% 46.1% 64.4% 43.4%
62.2% 65.9% 73.6% 75.2% 76.2% 77.7% 78.6% 79.2% 65.7% 53.9% 35.6% 56.6%
92.8% 62.5% 38.4% 26.0% 24.4% 8.0% 6.3% 5.0% 8.2% 7.2% 9.1% 9.3%
146.4% 113.9% 71.8% 61.9% 78.6% 75.3% 18.3% 24.3% 32.2% 28.9% 31.8% 34.8%
239.2% 186.0% 124.0% 100.3% 123.4% 83.3% 81.8% 77.4% 94.4% 72.4% 75.8% 63.1%
-177.0% -120.1% -50.4% -25.2% -47.2% -5.6% -3.2% 1.8% -28.7% -18.4% -40.2% -6.5%
34.1% 24.5% 14.4% 5.4% 3.9% 1.5% 0.4% 0.0% 0.0% 0.0% 0.0% 0.0%
-109.2% -144.7% -58.7% -30.6% -50.8% -5.2% -2.8% 1.9% -28.1% -17.5% -33.8% -16.9%
-5.2% -3.8% 7.7% 7.2% 0.0% 0.0% 0.1% 0.6% 0.5% 1.8% 2.2% 1.3%
-104.0% -140.9% -66.4% -37.5% -50.8% -5.3% -2.9% 1.3% -28.7% -19.3% -35.9% -18.2%
-73.4% -119.0% -43.5% -24.5% -46.5% -3.5% -2.1% 2.4% -27.3% -16.5% -32.4% -15.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?